These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 448641)

  • 1. Pharmacological evaluation of new calcium antagonists: 2-substituted 3-dimethylamino-5,6-methylenedioxyindenes. Effects on isolated hearts and coronary vessels.
    Piascik MF; Rahwan RG; Witiak DT
    J Pharmacol Exp Ther; 1979 Jul; 210(1):141-6. PubMed ID: 448641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evaluation of new calcium antagonists: 2-substituted 3-dimethylamino-5,6-methylenedioxyindenes.
    Rahwan RG; Faust MM; Witiak DT
    J Pharmacol Exp Ther; 1977 Apr; 201(1):126-37. PubMed ID: 850135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The methylenedioxyindenes, a novel class of "intracellular calcium antagonists": effects on contractility and on processes involved in regulating intracellular calcium homeostasis.
    Weishaar RE; Quade M; Schenden JA; Kaplan HR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):767-78. PubMed ID: 6655569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium-antagonism, a new principle in coronary vasodilation].
    Grün G; Fleckenstein A
    Minerva Med; 1975 May; 66(38):1838-45. PubMed ID: 805387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of vasopressin in isolated rat hearts.
    Kaygisiz Z; Kabadere TE; Dernek S; Erden SH
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):54-62. PubMed ID: 11211571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of amrinone on isolated heart preparations: comparative study with other inotropic agents].
    Raddino R; Metra M; Catellani E; Nodari S; Pelà G; Manca C; Dei Cas L
    Cardiologia; 1991 Sep; 36(9):729-34. PubMed ID: 1686991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
    Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
    J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of new calcium antagonists: 2-substituted 3-dimethylamino-5,6-methylenedioxyindenes. Effects on adrenomedullary catecholamine secretion.
    Piascik MF; Rahwan RG; Witiak DT
    J Pharmacol Exp Ther; 1978 Apr; 205(1):155-63. PubMed ID: 633080
    [No Abstract]   [Full Text] [Related]  

  • 15. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
    Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts.
    Zausig YA; Stowe DF; Zink W; Grube C; Martin E; Graf BM
    Anesth Analg; 2006 Jun; 102(6):1646-52. PubMed ID: 16717301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker.
    Kennedy RH; Owings R; Joseph J; Melchert RB; Hauer-Jensen M; Boerma M
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):340-4. PubMed ID: 16620298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs].
    Fleckenstein A
    Med Klin; 1975 Oct; 70(42):1665-74. PubMed ID: 1102892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.